Literature DB >> 18343331

Cancer and orofacial pain.

Dena J Fischer1, Gary D Klasser, Joel B Epstein.   

Abstract

Orofacial pain is commonly associated with cancer and may motivate patients to seek care from an oral and maxillofacial surgeon. Pain may be a presenting symptom of primary tumors, metastatic disease, systemic cancer, or distant non-metastasized cancer. Patients with head and neck cancer undergoing therapy may suffer treatment-induced complications, which are often associated with acute pain. Following cancer therapy, permanent changes to tissues may cause late effects of treatment that may result in chronic orofacial pains. Oral and maxillofacial surgeons should be knowledgeable regarding these orofacial pain presentations.

Entities:  

Mesh:

Year:  2008        PMID: 18343331     DOI: 10.1016/j.coms.2007.12.011

Source DB:  PubMed          Journal:  Oral Maxillofac Surg Clin North Am        ISSN: 1042-3699            Impact factor:   2.802


  6 in total

1.  Survival patterns in squamous cell carcinoma of the head and neck: pain as an independent prognostic factor for survival.

Authors:  Cielito C Reyes-Gibby; Karen O Anderson; Kelly W Merriman; Knox H Todd; Sanjay S Shete; Ehab Y Hanna
Journal:  J Pain       Date:  2014-07-17       Impact factor: 5.820

Review 2.  Cancer and Referred Facial Pain.

Authors:  Marcela Romero-Reyes; Antonia Teruel; Yi Ye
Journal:  Curr Pain Headache Rep       Date:  2015-08

3.  Predictors of long-term opioid treatment among patients who receive chemoradiation for head and neck cancer.

Authors:  Jung Hye Kwon; David Hui; Gary Chisholm; Eduardo Bruera
Journal:  Oncologist       Date:  2013-05-30

4.  Incidental finding of an extensive oropharyngeal mass in magnetic resonance imaging of a patient with temporomandibular disorder: A case report.

Authors:  Temitope T Omolehinwa; Mel Mupparapu; Sunday O Akintoye
Journal:  Imaging Sci Dent       Date:  2016-12-20

5.  Comparison of orofacial pain of patients with different stages of precancer and oral cancer.

Authors:  Yanjie Yang; Peipei Zhang; Wenlu Li
Journal:  Sci Rep       Date:  2017-03-16       Impact factor: 4.379

6.  Allicin Could Potentially Alleviate Oral Cancer Pain by Inhibiting "Pain Mediators" TNF-alpha, IL-8, and Endothelin.

Authors:  Abdulwahab H Alamir; Shankargouda Patil
Journal:  Curr Issues Mol Biol       Date:  2021-05-23       Impact factor: 2.976

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.